Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. (Q54659755)

2 June 2018

title

Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. (English)

1 reference

2 June 2018

main subject

bilateral breast cancer

1 reference

8

1 reference

2 June 2018

author name string

Elrasheid A H Kheirelseid

1

1 reference

2 June 2018

Hanzali Jumustafa

2

1 reference

2 June 2018

Nicola Miller

3

1 reference

2 June 2018

Catherine Curran

4

1 reference

2 June 2018

Karl Sweeney

5

1 reference

2 June 2018

Carmel Malone

6

1 reference

2 June 2018

Ray McLaughlin

7

1 reference

2 June 2018

Michael J Kerin

9

1 reference

2 June 2018

language of work or name

English

0 references

publication date

28 July 2010

1 reference

2 June 2018

Breast Cancer Research and Treatment

published in

1 reference

2 June 2018

volume

126

1 reference

2 June 2018

issue

1

1 reference

2 June 2018

page(s)

131-140

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1007/s10549-010-1057-y

exact match

0 references

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Bilateral primary breast cancer: a prospective study of disease incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Contralateral breast cancer: factors associated with stage and size at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Incidence and outcomes of contralateral breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Screening women at increased risk with MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Reoperations after prophylactic mastectomy with or without implant reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Bilateral breast-conserving therapy for bilateral breast cancer: results and consideration of radiation technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Adjuvant radiotherapy and risk of contralateral breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

Genetic implications of bilateral breast cancer: a population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1057-Y

10.1007/S10549-010-1057-Y

21 January 2018

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018